Recent studies have indicated that METTL3 plays an oncogenic role in PCa (Cai et al., 2019; Li et al., 2020a; Li et al., 2020b; Ma et al., 2020; Yuan et al., 2020; Chen et al., 2021a; Ma et al., 2021; Liu et al., 2022a; Wang et al., 2022a; Mao et al., 2022; Chen et al., 2023). Here, METTL3 is linked to posterior cortical atrophy.